Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid-free versus conventional tacrolimus-based immunosuppression after first liver transplant
2005-000786-19Phase 4Completed
- Sponsor
- Cima Universidad de Navarra
- Start
- Feb 2006
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus, mycophenolate mofetil and prednisone in liver transplant and cardiac morbidity (2 arms), sponsored by Cima Universidad de Navarra. Started Feb 2006; status: completed.
02
Drugs
tacrolimusmycophenolate mofetilprednisone
03
Conditions
liver transplantcardiac morbidity
Beyond the preview
Go deeper on 2005-000786-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000786-19.